A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
Clinical trial NCT02326272 · COMPLETED
Trial details
- NCT number
- NCT02326272
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-15
- Primary completion
- 2016-01-05
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.